Evaluating New Formulation of Therapeutic HSV-2 Vaccine
NCT02515175
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
131
Enrollment
INDUSTRY
Sponsor class
Conditions
Genital Herpes Simplex Type 2
Interventions
BIOLOGICAL:
Matrix-M2
BIOLOGICAL:
GEN-003
DRUG:
Placebo
Sponsor
Genocea Biosciences, Inc.